| Financial Year |
March 31 2023 |
| Monetary Funds |
1,193,780,609.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
39,543,256.00 |
| Accounts Receivable |
853,620,968.00 |
| Advances to Suppliers |
238,042,684.00 |
| Other Receivables |
26,473,716.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,800,000.00 |
| Inventories |
1,390,038,884.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
76,099,321.00 |
| Total Current Assets |
4,198,128,342.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
188,451,069.00 |
| Investment Properties |
-- |
| Fixed Assetes |
2,394,445,456.00 |
| Under-construction Projects |
320,077,243.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
341,122,965.00 |
| R&D expenses |
-- |
| Goodwill |
54,514,992.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
95,453,743.00 |
| Other Non-Current Assets |
214,700,965.00 |
| Sub-Total of Non-Current Assets |
3,719,070,266.00 |
| Total Assets |
7,917,198,608.00 |
| Short-Term Loans |
319,642,142.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
943,259,814.00 |
| Accounts Payable |
964,565,601.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,357,399.00 |
| Taxes Payable |
16,721,305.00 |
| Interest Payable |
765,363.00 |
| Dividend Payable |
-- |
| Other payables |
234,630,761.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
189,589,896.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,737,765,303.00 |
| Long-term Loans |
859,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
424,426.00 |
| Deferred Income Tax Liabilities |
31,762,557.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,008,820,056.00 |
| Total Liabilities |
3,746,585,359.00 |
| Paid-In Capital(Or Share Stock) |
1,494,253,157.00 |
| Capital Surplus |
758,338,192.00 |
| Surplus Reserve |
46,574,854.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,395,821,747.00 |
| Minority Stockholder's Interest |
481,628,337.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,688,984,912.00 |
| Owner's Equity（Stockholder's Equity） |
4,170,613,249.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,917,198,608.00 |
